X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (617) 617
male (308) 308
hypereosinophilic syndrome - genetics (275) 275
hematology (257) 257
hypereosinophilic syndrome (253) 253
index medicus (241) 241
imatinib mesylate (219) 219
adult (204) 204
receptor, platelet-derived growth factor alpha - genetics (198) 198
hypereosinophilic syndrome - drug therapy (190) 190
female (185) 185
middle aged (170) 170
idiopathic hypereosinophilic syndrome (168) 168
mrna cleavage and polyadenylation factors - genetics (166) 166
benzamides (158) 158
oncology (157) 157
oncogene proteins, fusion - genetics (150) 150
eosinophilia (146) 146
leukemia (142) 142
imatinib (139) 139
pyrimidines - therapeutic use (137) 137
piperazines - therapeutic use (135) 135
hypereosinophilic syndrome - diagnosis (131) 131
aged (109) 109
hypereosinophilic syndrome - pathology (99) 99
mutation (97) 97
animals (95) 95
chronic eosinophilic leukemia (94) 94
antineoplastic agents - therapeutic use (93) 93
chronic disease (81) 81
tyrosine kinase (81) 81
fusion (80) 80
immunology (79) 79
chronic myeloid-leukemia (70) 70
treatment outcome (70) 70
protein kinase inhibitors - therapeutic use (67) 67
diagnosis (62) 62
eosinophilia - genetics (62) 62
platelet-derived growth factor (57) 57
myeloproliferative disorders - genetics (56) 56
medicine, general & internal (55) 55
diagnosis, differential (54) 54
eosinophils (54) 54
hypereosinophilic syndrome - complications (54) 54
disease (51) 51
chronic myelomonocytic leukemia (50) 50
translocation, genetic (50) 50
allergy (48) 48
genetic aspects (48) 48
hypereosinophilic syndrome - immunology (47) 47
therapy (47) 47
adolescent (46) 46
cancer (46) 46
mice (46) 46
classification (45) 45
fip1l1-pdgfra (45) 45
in situ hybridization, fluorescence (45) 45
eosinophilia - pathology (44) 44
interleukin-5 (44) 44
care and treatment (43) 43
pdgfra (43) 43
analysis (42) 42
child (42) 42
disorders (42) 42
reverse transcriptase polymerase chain reaction (41) 41
systemic mastocytosis (41) 41
eosinophils - pathology (40) 40
hypereosinophilia (40) 40
receptor, platelet-derived growth factor beta - genetics (40) 40
eosinophilia - diagnosis (39) 39
factor receptor-beta (39) 39
pathology (39) 39
research (39) 39
expression (38) 38
hypereosinophilic syndrome - etiology (37) 37
medicine & public health (37) 37
molecular sequence data (37) 37
receptor, platelet-derived growth factor alpha - metabolism (37) 37
aged, 80 and over (36) 36
chronic myelogenous leukemia (36) 36
hypereosinophilic syndrome - blood (36) 36
article (35) 35
bone marrow (35) 35
bone marrow - pathology (35) 35
eosinophilia - drug therapy (35) 35
hypereosinophilic syndrome - metabolism (35) 35
hypereosinophilic syndrome - therapy (35) 35
pyrimidines - administration & dosage (35) 35
remission induction (34) 34
abridged index medicus (33) 33
acute lymphoblastic-leukemia (33) 33
base sequence (33) 33
gastrointestinal stromal tumors (33) 33
gene rearrangement (33) 33
genes (33) 33
oncogene proteins, fusion - metabolism (33) 33
young adult (33) 33
eosinophilia - etiology (32) 32
eosinophilic leukemia (32) 32
mrna cleavage and polyadenylation factors - metabolism (32) 32
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (650) 650
French (20) 20
Japanese (10) 10
German (9) 9
Chinese (8) 8
Russian (5) 5
Dutch (3) 3
Korean (3) 3
Czech (1) 1
Danish (1) 1
Polish (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2008, Volume 358, Issue 12, pp. 1215 - 1228
Journal Article
Blood, ISSN 0006-4971, 02/2017, Volume 129, Issue 6, pp. 704 - 714
Molecular diagnostics has generated substantial dividends in dissecting the genetic basis of myeloid neoplasms with eosinophilia. The family of diseases... 
GROWTH-FACTOR RECEPTOR | BCR-JAK2 FUSION GENE | MYELOPROLIFERATIVE NEOPLASM | TYROSINE KINASE | TERM-FOLLOW-UP | IDIOPATHIC HYPEREOSINOPHILIC SYNDROME | FIP1L1-PDGFRA FUSION | HEMATOLOGY | SYSTEMIC MASTOCYTOSIS | IMATINIB MESYLATE | PCM1-JAK2 FUSION | Eosinophilia - therapy | Oncogene Proteins, Fusion - metabolism | Leukemia - pathology | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Humans | Gene Expression Regulation, Neoplastic | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | fms-Like Tyrosine Kinase 3 | Antineoplastic Agents - therapeutic use | Myeloproliferative Disorders - pathology | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Receptor, Platelet-Derived Growth Factor beta - genetics | Myeloproliferative Disorders - genetics | Transplantation, Homologous | Eosinophilia - pathology | Hypereosinophilic Syndrome - diagnosis | Receptor, Platelet-Derived Growth Factor beta - antagonists & inhibitors | Receptor, Platelet-Derived Growth Factor alpha - antagonists & inhibitors | Janus Kinase 2 - metabolism | Eosinophilia - genetics | Hypereosinophilic Syndrome - pathology | Hypereosinophilic Syndrome - therapy | Eosinophilia - diagnosis | Janus Kinase 2 - antagonists & inhibitors | Leukemia - genetics | Receptor, Platelet-Derived Growth Factor beta - metabolism | Myeloproliferative Disorders - diagnosis | Proto-Oncogene Proteins c-abl - genetics | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Myeloproliferative Disorders - therapy | Janus Kinase 2 - genetics | Hematopoietic Stem Cell Transplantation | Leukemia - therapy | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Receptor, Platelet-Derived Growth Factor alpha - genetics | Leukemia - diagnosis | Proto-Oncogene Proteins c-abl - metabolism | Hypereosinophilic Syndrome - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2006, Volume 133, Issue 5, pp. 468 - 492
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2003, Volume 348, Issue 13, pp. 1201 - 1214
Journal Article
Rheumatology, ISSN 1462-0324, 10/2011, Volume 50, Issue 10, pp. 1823 - 1827
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2008, Volume 143, Issue 5, pp. 707 - 715
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2014, Volume 89, Issue 3, pp. 325 - 337
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 774 - 777
Journal Article
Medicine, ISSN 0025-7974, 10/2014, Volume 93, Issue 17, pp. 255 - 266
The CD3-CD4+ aberrant T-cell phenotype is the most described in the lymphoid variant of hypereosinophilic syndrome (L-HES), a rare form of HES. Only a few... 
POPULATION | MEDICINE, GENERAL & INTERNAL | CORONARY ANEURYSMS | IDIOPATHIC EOSINOPHILIA | TH2 LYMPHOCYTES | LYMPHOCYTIC VARIANT | PROLIFERATION | INTERLEUKIN-5 | CLONES | Hypereosinophilic Syndrome - drug therapy | CD3 Complex | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Phenotype | Adolescent | Adult | Female |